EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

166 hedge funds and large institutions have $574M invested in Eagle Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 70 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
-5
Holders Change %
-2.92%
% of All Funds
2.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
50
Reduced
70
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
HW
176
Hancock Whitney
Mississippi
-$234K -5,515 Closed
CGH
177
Crossmark Global Holdings
Texas
-$231K -5,428 Closed
SO
178
STRS Ohio
Ohio
-$67K -1,600 Closed
Simplex Trading
179
Simplex Trading
Illinois
-$59K -1,410 Closed
NFG
180
Next Financial Group
Texas
-$15K -358 Closed
GT
181
Glenmede Trust
Pennsylvania
-$10K -258 Closed
QT
182
Quantbot Technologies
New York
-$9K -225 Closed
CFD
183
Creative Financial Designs
Indiana
-$7K -165 Closed